P
Paola Frati
Researcher at Sapienza University of Rome
Publications - 195
Citations - 2921
Paola Frati is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 23, co-authored 159 publications receiving 1916 citations. Previous affiliations of Paola Frati include American Board of Legal Medicine & University of Sannio.
Papers
More filters
Journal ArticleDOI
A national survey of Italian physicians' attitudes towards end-of-life decisions following the death of Eluana Englaro: reply to M.Y. Rady.
Journal ArticleDOI
Improve Healthcare quality through Mortality Committee: Retrospective analysis of Bambino Gesù Children Hospital's ten years' experience 2008-2017
Caterina Offidani,Maria Lodise,Vittorio Gatto,Paola Frati,Stefano D'Errico,Marta Ciofi Degli Atti,Massimiliano Raponi +6 more
TL;DR: In this paper, the authors present the experience of the Mortality Committee of Bambino Gesu Children Hospital (OPBG), which has instituted a process of systematic revision of all in-hospital deaths conducted by a multidisciplinary team.
Journal ArticleDOI
Asbestos and onset of mesothelioma: case report
Tiziana Caciari,Teodorico Casale,Angela Sancini,Elisabete Weiderpass,Paola Frati,S. De Sio,F Sinibaldi,C. Di Pastena,B. Scala,P. F. M. Buccisano,Assuntina Capozzella,Di Giorgio,Colasanti,Marchione S,M. Penna,F. Tomei,Gianfranco Tomei,Maria Valeria Rosati +17 more
TL;DR: La diagnosi di malattia professionale correlata ad amianto non è semplice né automatica, occorre rispettare una serie oferta di criteri, verificando markers immunoistochimici, monitoraggi biologici ed ambientali, anche personali, per accertar una correlazione effettiva.
Journal ArticleDOI
Cannabinoids and brain damage: A systematic review on a frequently overlooked issue.
Matteo Scopetti,D. Morena,Federico Manetti,Alessandro Santurro,Nicola Di Fazio,Stefano D' Errico,Martina Padovano,Paola Frati,Vittorio Fineschi +8 more
TL;DR: The present systematic review aims to summarize the available evidence regarding the mechanism of cannabinoids-induced brain damage as a substrate of neurological, psychiatric, and behavioral effects and to reinforce the toxic-epidemiologic monitor of new substances market.